Ameritas Investment Partners’s Protara Therapeutics TARA Stock Holding History

Ameritas Investment Partners’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.2K	Hold	3,298	–	–	﹤0.01%	2658
2025 Q4	$17.6K	Hold	3,298	–	–	﹤0.01%	2698
2025 Q3	$14.3K	Hold	3,298	–	–	﹤0.01%	2826
2025 Q2	$9.99K	Buy	+3,298	New	+$11.4K	﹤0.01%	2981
2021 Q2	–	Sell	-178	Closed	-$3K	–	3222
2021 Q1	$3K	Hold	178	–	–	﹤0.01%	3062
2020 Q4	$4K	Hold	178	–	–	﹤0.01%	3007
2020 Q3	$3K	Hold	178	–	–	﹤0.01%	3051
2020 Q2	$5K	Buy	+178	New	+$5.51K	﹤0.01%	2965

Other funds holding TARA

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Ameritas Investment Partners's TARA Position: Q1 2026 in Review

Ameritas Investment Partners held its Protara Therapeutics (TARA) position steady in Q1 2026 at 3,298 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2658.

Ameritas Investment Partners first reported a position in TARA in Q2 2020 and has held it in 8 quarters since. The position peaked at $17.6K in Q4 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

Ameritas Investment Partners held 3,298 shares of Protara Therapeutics worth $17.2K as of Q1 2026.
Ameritas Investment Partners left its Protara Therapeutics share count unchanged in Q1 2026.
Protara Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2658 holding.
Ameritas Investment Partners first reported a position in Protara Therapeutics in Q2 2020 and has held it in 8 quarters since.
Ameritas Investment Partners's Protara Therapeutics position peaked at $17.6K in Q4 2025.
114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.